DossierENTITY

Erasca

Coverage of Erasca in the Nexus archive.

Earliest in view: Apr 28 · 17:23 UTCMost recent: Apr 28 · 17:23 UTC

Co-mentioned in this coverage

Recent coverage

HEALTHApr 28 · 17:23 UTCBLOOMBERG
Cancer Drug Developer Erasca Sinks by Record 55% After Patient Death
Cancer drug developer Erasca's stock plummeted 55% following a patient death linked to its clinical trials. The significant drop highlights investor concerns over drug safety and regulatory risks.